Advertisement
MRI classifier identifies a subset of patients with disease marked by cortical atrophy, not demyelination
Recognizing this association aids risk assessment before starting novel immunotherapies
New findings have important implications for clinical trial design
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Advertisement